Inactivated TBE vaccine
Tick-borne encephalitis vaccine
Brand names: TicoVac
Adult dose
Dose: 0.5mL IM at days 0, 1-3 months, 5-12 months (rapid: days 0, 14)
Route: IM
Frequency: x3 doses
Clinical pearls
- Travellers to endemic areas (forested central/eastern Europe, Russia, Asia) with tick exposure
- Boost every 3-5 years
Contraindications
- Severe egg/component allergy
- Acute febrile illness
Side effects
- Injection-site reactions
- Fever
- Headache
- Myalgia
Interactions
- Immunosuppressives reduce response
Reference: BNF; UKHSA Green Book Ch.31; https://bnf.nice.org.uk/drugs/tick-borne-encephalitis-vaccine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023